Sorry, you need to enable JavaScript to visit this website.

Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients

A Three Month Prospective Open Label Study of Therapy With Fragmin
(Dalteparin Sodium Injection) in Children With Venous Thromboembolism With or Without
Malignancies

Category & Conditions: Cardiovasular Diseases and Conditions
Medicine: FRAGMIN®(DALTEPARIN SODIUM INJECTION)
ClinicalTrials.gov Identifier (NCT): NCT00952380
Protocol ID: A6301094
PrintDownload
Open Plain Language Summary Result: Click here